Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples